-
1
-
-
77349109163
-
-
Health and Fitness Survey; Dublin: Institute of European Food Studies 2000
-
Health and Fitness Survey; Dublin: Institute of European Food Studies 2000
-
-
-
-
2
-
-
0004318660
-
Obesity. Preventing and managing the global epidemic
-
Obesity. Preventing and managing the global epidemic. Report of a WHO Consultation on obesity, 1997
-
(1997)
Report of a WHO Consultation on obesity
-
-
-
3
-
-
77349116032
-
-
National Health Examination Surveys
-
National Health Examination Surveys. Endocrinol Metab Clin N Am 2003.
-
(2003)
Endocrinol Metab Clin N Am
-
-
-
5
-
-
9644254084
-
Tendências do peso em Portugal no final do século XX.
-
Lacerda Nobre E, Macedo JA, Castro J. Tendências do peso em Portugal no final do século XX. Acta Med Port 2004; 17 205-9.
-
(2004)
Acta Med Port
, vol.17
, pp. 205-209
-
-
Lacerda Nobre, E.1
Macedo, J.A.2
Castro, J.3
-
6
-
-
0027966932
-
Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men
-
Chan JM, Rimm EB, Colditz GA et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961-9.
-
(1994)
Diabetes Care
, vol.17
, pp. 961-969
-
-
Chan, J.M.1
Rimm, E.B.2
Colditz, G.A.3
-
8
-
-
0030989520
-
Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study
-
Carey VJ, Walters EE, Colditz GA et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol. 1997;145:614-9.
-
(1997)
Am J Epidemiol
, vol.145
, pp. 614-619
-
-
Carey, V.J.1
Walters, E.E.2
Colditz, G.A.3
-
9
-
-
0022402245
-
Health implication of overweight and obesity in the United States
-
Van Itallie TB. Health implication of overweight and obesity in the United States. Ann Int Med. 1985;103:983-8
-
(1985)
Ann Int Med
, vol.103
, pp. 983-988
-
-
Van Itallie, T.B.1
-
10
-
-
0022379345
-
Overweight and cancer
-
Garfinkel L. Overweight and cancer. Ann Int Med. 1985;103: 1047-52.
-
(1985)
Ann Int Med
, vol.103
, pp. 1047-1052
-
-
Garfinkel, L.1
-
13
-
-
0033533859
-
Body-mass index and mortality in a prospective cohort of US adults
-
Calle EE, Thun MJ, Petrelli JM et al. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999; 341:1097-105.
-
(1999)
N Engl J Med
, vol.341
, pp. 1097-1105
-
-
Calle, E.E.1
Thun, M.J.2
Petrelli, J.M.3
-
14
-
-
0032742418
-
The disease burden associated with overweight and obesity
-
Must A, Spadano J, Coakley EH et al. The disease burden associated with overweight and obesity. JAMA 1999; 282:1523-9.
-
(1999)
JAMA
, vol.282
, pp. 1523-1529
-
-
Must, A.1
Spadano, J.2
Coakley, E.H.3
-
15
-
-
0029012215
-
The primary prevention of coronary heart disease in women
-
Rich-Edwards JW, Manson JE, Hennekens CH et al. The primary prevention of coronary heart disease in women. N Eng J Med 1995;332:1758-66
-
(1995)
N Eng J Med
, vol.332
, pp. 1758-1766
-
-
Rich-Edwards, J.W.1
Manson, J.E.2
Hennekens, C.H.3
-
16
-
-
27644457743
-
Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: A case-control study
-
Yusuf S, Hawken S, Ôunpuu S et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-9
-
(2005)
Lancet
, vol.366
, pp. 1640-1649
-
-
Yusuf, S.1
Hawken, S.2
Ôunpuu, S.3
-
17
-
-
30444456396
-
Midlife body mass index and hospitalization and mortality in older age
-
Yan LL, Daviglus ML, Liu K et al. Midlife body mass index and hospitalization and mortality in older age. JAMA, 2006; 295:190-8
-
(2006)
JAMA
, vol.295
, pp. 190-198
-
-
Yan, L.L.1
Daviglus, M.L.2
Liu, K.3
-
18
-
-
77349126966
-
-
The IDF consensus worldwide definition of the metabolic syndrome April
-
The IDF consensus worldwide definition of the metabolic syndrome April 2005. www.idf.org
-
(2005)
-
-
-
19
-
-
0032543870
-
Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
-
for the European Multicentre Orlistat Study Group
-
Sjöstron L, Rissanen A, Andersen T, for the European Multicentre Orlistat Study Group. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998; 352:167-72.
-
(1998)
Lancet
, vol.352
, pp. 167-172
-
-
Sjöstron, L.1
Rissanen, A.2
Andersen, T.3
-
20
-
-
0033585499
-
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. A randomized controlled trial
-
Davidson M H, Hauptman J, DiGirolamo M et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. A randomized controlled trial. JAMA 1999; 281:235-42.
-
(1999)
JAMA
, vol.281
, pp. 235-242
-
-
Davidson, M.H.1
Hauptman, J.2
DiGirolamo, M.3
-
21
-
-
1042303480
-
Xenical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study. A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients
-
Torgerson JS, Hauptman J, Boldrin MN et al. Xenical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study. A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27:155-61
-
(2004)
Diabetes Care
, vol.27
, pp. 155-161
-
-
Torgerson, J.S.1
Hauptman, J.2
Boldrin, M.N.3
-
22
-
-
12744274872
-
Reduction of body weight and co-morbidities by orlistat: The XXL - Primary Health Care Trial
-
Wirth A. Reduction of body weight and co-morbidities by orlistat: The XXL - Primary Health Care Trial. Diab Obes Metab, 2005;7:21-7
-
(2005)
Diab Obes Metab
, vol.7
, pp. 21-27
-
-
Wirth, A.1
-
23
-
-
0026753155
-
Beneficial health effects of modest weight loss
-
Goldstein D J. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992;6: 397-415
-
(1992)
Int J Obes Relat Metab Disord
, vol.6
, pp. 397-415
-
-
Goldstein, D.J.1
-
24
-
-
12244289269
-
Pharmacological management of obesity
-
Hanif MW and Kumer S. Pharmacological management of obesity. Expert Opin Pharmacother 2002; 3:1711-8.
-
(2002)
Expert Opin Pharmacother
, vol.3
, pp. 1711-1718
-
-
Hanif, M.W.1
Kumer, S.2
-
25
-
-
17144382751
-
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
-
for the RIO-Europe Study Group
-
Van Gaal L, Rissanen AM, Scheen AK, for the RIO-Europe Study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005; 365:1389-97
-
(2005)
Lancet
, vol.365
, pp. 1389-1397
-
-
Van Gaal, L.1
Rissanen, A.M.2
Scheen, A.K.3
-
26
-
-
0034516930
-
Effects of sibutramine on weight maintenance after weight loss: A randomized trial
-
for the STORM Study Group
-
James WPT, Astrup A, Finer N, for the STORM Study Group. Effects of sibutramine on weight maintenance after weight loss: a randomized trial. Lancet 2000; 356: 2119-25
-
(2000)
Lancet
, vol.356
, pp. 2119-2125
-
-
James, W.P.T.1
Astrup, A.2
Finer, N.3
-
27
-
-
0033629936
-
Weight loss, weight maintenance and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity
-
Rössner S, Sjöstron L, Noack R et al. Weight loss, weight maintenance and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obes Res 2000; 8: 49-61
-
(2000)
Obes Res
, vol.8
, pp. 49-61
-
-
Rössner, S.1
Sjöstron, L.2
Noack, R.3
-
28
-
-
0034621494
-
Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults
-
Heymsfield SB, Segal K R, Hauptman J et al. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 2000; 160: 1321-6.
-
(2000)
Arch Intern Med
, vol.160
, pp. 1321-1326
-
-
Heymsfield, S.B.1
Segal, K.R.2
Hauptman, J.3
-
29
-
-
0031904104
-
Role of orlistat in the treatment of obese patients with type 2 diabetes
-
Hollander PA, Elbein S C. Hirsch IB et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. Diabetes Care 1998; 21: 1288-94
-
(1998)
Diabetes Care
, vol.21
, pp. 1288-1294
-
-
Hollander, P.A.1
Elbein, S.C.2
Hirsch, I.B.3
-
30
-
-
0028866609
-
Review of Limited Systemic Absorption of Orlistat, a Lipase Inhibitor, in Healthy Human Volunteers
-
Zhi J, Melia AT, Eggers H, Joly R, Patel IH. Review of Limited Systemic Absorption of Orlistat, a Lipase Inhibitor, in Healthy Human Volunteers. Clin Pharmacol 1995;35:1103-1108
-
(1995)
Clin Pharmacol
, vol.35
, pp. 1103-1108
-
-
Zhi, J.1
Melia, A.T.2
Eggers, H.3
Joly, R.4
Patel, I.H.5
|